One-Pot Synthesis of Biaryl Lactones by Sonogashira Cross-Coupling Reactions
70 eV): m/z (%)=288 ([M]+, 100), 260 (41), 231 (51), 203
In conclusion, we have reported the one-pot syn-
thesis of biaryl lactones by Sonogashira reaction of 4-
chloro-2-oxo-2H-chromene-3-carbaldehyde and subse-
quent cyclocondensation with 1,3-dicarbonyl com-
pounds. The cyclization proceeds by a novel domino
[5+1]cyclization/deacetylation reaction. From a prep-
arative viewpoint, the substitution pattern of the
products is not readily available by other methods.
From a methodology viewpoint, the domino process
reported has, to the best of our knowledge, not been
reported so far and might be of general interest. At
present, we are exploring the scope of the reaction re-
ported herein and its application to other halogenated
enals.
(42), 189 (43), 101 (14); HR-MS (EI): m/z=288.0789, calcd.
for C19H12O3 ([M]+): 288.0781.
Acknowledgements
Financial support by the State of Mecklenburg-Vorpommern,
by the DAAD (scholarship for M.S.A.A.) and by the BMBF
(Remedis-Verbundprojekt, Grant No. 03IS2081A) is grateful-
ly acknowledged.
References
[1] a) H. W. T. Sidwell, L. Fritz, C. Tamm, Helv. Chim.
Acta 1971, 54, 207; b) C. Tamm, Arzneim.-Forsch. 1972,
22, 1776; c) H. Raistrick, C. E. Stilkings, R. Thomas,
Biochemistry 1953, 55, 421; d) R. Pero, W. D. M.
Harvan, C. Blois, Tetrahedron Lett. 1973, 945;
Experimental Section
General Procedure for the Synthesis of 5a–n
To a solution of 1 (0.20 g, 1.0 mmol) in THF (7–8 mL) was
e) Rçmpp – Lexikon NaACHTNUGTREGtNUNN urACHTUNRTEGNGsNUN tofACTHNUGTRENfGUNN e, (Eds.: W. Steglich, B.
added K2CO3 (0.20 g, 1.5 equiv.). Under a continuous supply
of argon were added PdCl2ACHTNUGTRNEUNG(PPh3)2 (4 mol%) and CuI
Fugmann, S. Lang-Fugmann), Thieme, Stuttgart, 1997.
[2] a) J. M. Sayer, Y. Haruhiko, A. W. Wood, A. H.
Conney, D. M. Jerina, J. Am. Chem. Soc. 1982, 104,
5562; b) Y. A. G. P. Gunawardana, N. S. Kumar,
M. U. S. Sultanbawa, Phytochemistry 1979, 18, 1017.
[3] For antibiotic and antitumor activity, see: a) B. I. Alo,
A. Kandil, P. A. Patil, M. J. Sharp, M. A. Siddiqui, V.
Snieckus, J. Org. Chem. 1991, 56, 3763, and refs.[6–10]
cited therein. For the inhibition of endothelic cells, see:
b) J. M. Schmidt, G. B. Tremblay, M. Page, J. Mercure,
M. Feher, R. Dunn-Dufault, M. G. Peter, P. R. Redden,
J. Med. Chem. 2003, 46, 1289. For the inhibition of oes-
trogen receptor growth, see: c) J. Pandey, A. K. Jha, K.
Hajela, Bioorg. Med. Chem. 2004, 12, 2239.
[4] For intramolecular Pd(II)-catalyzed coupling reactions
of aryl benzoates, see: a) G. Bringmann, H. Reuscher,
Tetrahedron Lett. 1989, 30, 5249. For the combination
of directed ortho-metalations (DoM) with Suzuki reac-
tions, see: b) B. I. Alo, A. Kandil, P. A. Patil, M. J.
Sharp, M. A. Siddiqui, V. Snieckus, J. Org. Chem. 1991,
56, 3763. For the Pd-catalyzed reaction of boroxarenes,
prepared from ortho-hydroxybiaryls, with carbon mon-
oxide, see: c) Q. J. Zhou, K. Worm, R. E. Dolle, J. Org.
Chem. 2004, 69, 5147.
(7 mol%), followed by dropwise addition (an interval of
2 min) of 2 (1.5 equiv.). The reaction mixture was allowed to
stir at room temperature for 8 to 10 h and monitored by
TLC. To the same reaction vessel was dropwise added the
1,3-dicarbonyl compound (1.5 equiv.). The reaction mixture
was then stirred at 508C for 5 to 6 h. After completion of
the reaction, the reaction mixture was acidified by addition
of a few drops of hydrochloric acid (1M). The mixture was
then extracted with ethyl acetate. The solvent was removed
under reduced pressure. The residue was purified by column
chromatography (silica gel, heptanes/EtOAc).
Methyl 6-oxo-9-phenyl-6H-benzo[c]chromene-8-carbox-
ylate (5f): Starting with 1 (0.20 g, 1.0 mmol), K2CO3 (0.20 g,
1.5 equiv.), PdCl2ACHTUNGTRENNUNG(PPh3)2 (4 mol%), CuI (7 mol%), 2d
(0.15 g, 1.5 equiv.), and 4d (0.174 g, 1.5 equiv.), 5d was isolat-
ed by chromatography as a white crystalline solid; yield:
1
0.155 g (47%); mp 185–1878C. H NMR (250 MHz, CDCl3):
d=3.66 (s, 3H, OCH3), 7.24–7.36 (m, 4H, Ar-H), 7.37–7.50
(m, 4H, Ar-H), 7.98–8.01 (m, 2H, Ar-H), 8.81 (s, 1H, Ar-
H); 13C NMR (250 MHz, CDCl3): d=52.3 (OCH3), 117.2
(C), 118.0 (CH), 119.9 (C), 123.3, 124.3, 124.8 (CH), 128.2
(2CH), 128.4 (3CH), 131.3 (C), 131.6, 132.9 (CH), 136.8,
140.0, 148.85 (C), 152.0, 160.3, 167.0 (CO); IR (ATR): n=
2947 (w), 1716 (s), 1608(m), 1228 (s), 1184 (m) 1083(m),
977(m), 751 (s), 703 cmÀ1 (m); GC-MS (EI, 70 eV): m/z
(%)=330 ([M]+, 97), 330 (100), 271 (8), 255 (20), 226 (25);
HR-MS (EI): m/z=330.0884, calcd. for C21H14O3 ([M]+):
330.0886.
[5] I. Hussain, V. T. H. Nguyen, M. A. Yawer, T. T. Dang,
C. Fischer, H. Reinke, P. Langer, J. Org. Chem. 2007,
72, 6255.
[6] B. Appel, N. N. R. Saleh, P. Langer, Chem. Eur. J. 2006,
12, 1221.
[7] O. Fatunsin, V. O. Iaroshenko, S. O. Dudkin, S.
Mkrtchyan, A. Villinger, P. Langer, Tetrahedron Lett.
2010, 51, 4693.
2-Oxo-4-(p-tolylethynyl)-2H-chromene-3-carbaldehyde
(3a): yellow crystalline solid; mp 188–1908C. 1H NMR
(300 MHz, CDCl3): d=2.36 (s, 3H), 7.19–7.37 (m, 4H, Ar-
H), 7.58–7.63 (m, 3H, Ar-H), 8.12 (dd, J=8.07 Hz, J=
[8] A. M. M. El-Saghier, M. B. Naili, B. Kh. Rammash,
N. A. Saleh, K. M. Kreddan, Arkivoc 2007, 83.
1.38 Hz, 1H, Ar-H), 10.47
N
[9] For a review, see: P. Langer, Synthesis 2002, 441.
[10] For reviews, see: a) B. Willy, T. J. J. Mꢀller, Curr. Org.
Chem. 2009, 13, 1777; b) B. Willy, T. J. J. Mꢀller, Arki-
voc 2008, 195; see also: c) E. Merkul, C. Boersch, W.
Frank, T. J. J. Mꢀller, Org. Lett. 2009, 11, 2269;
d) D. M. D’Souza, C. Muschelknautz, F. Rominger,
CDCl3): d=21.91 (CH3), 83.30, 113.41, 117.21, 117.90,
118.66, 120.59 (C), 125.07, 128.77 (CH), 129.69, (2CH),
133.22 (2CH), 134.65 (CH), 140.10, 142.34 (C), 154.23,
159.68 (CO) 187.67 (CHO); IR (ATR): n=2858 (w), 2182
(s), 1698 (m), 1268 (m), 819 (s), 747 cmÀ1 (s); GC-MS (EI,
Adv. Synth. Catal. 2012, 354, 803 – 806
ꢂ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
805